Alexion Pharmaceuticals, Inc.

NASDAQ: ALXN
$103.14
+$0.60 (+0.6%)
Closing price February 21, 2020

Biotech Short Sellers Focus on a Couple Favorites

The short interest data are out for the most recent settlement date, January 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Short Sellers Wary on Major Biotechs

The short interest data are out for the most recent settlement date, January 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Amazon, Facebook, Starbucks, Tesla and More Major Earnings Coming This Week

This week will be perhaps the biggest week of earnings season, with many major names reporting. Last week we saw positive results lift the S&P 500, Dow Jones industrial average, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alexion, American Water Works, Apple, Schwab, Crowdstrike, FedEx, IBM, Microsoft, Nvidia, Ryanair, Tesla and More

Stocks have been putting in new all-time highs at the start of 2020 after an incredibly strong 2019. The futures were indicated higher on Monday morning ahead of this week's ...
Read Full Story »

Major Biotechs Have Short Sellers Excited

The short interest data are out for the most recent settlement date, December 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Major Biotechs See Rising Short Interest

The short interest data are out for the most recent settlement date, December 13. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Credit Suisse Has 3 Top Picks for 50% or More Implied Upside in 2020

With 2019 fading fast and 2020 rapidly approaching, investors are having to reflect on where the markets started out this year and where they are likely going in in the ...
Read Full Story »

Major Biotechs See a Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, November 29. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Short Sellers Run For Cover From Major Biotechs

The short interest data are out for the most recent settlement date, November 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Major Biotechs See Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Stocks were mixed in the premarket on Tuesday and the day was just looking for direction after last week's all-time highs. Investors still have a lot of pressing issues and ...
Read Full Story »

Major Biotechs See Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, October 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

How Biotech and Big Pharma Have Upside Heading Into Earnings

Biotech and many of the so-called Big Pharma have been duds in 2019. Despite many FDA approvals and some powerful mergers and royalty deals, the political pressure around drug pricing ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Stocks were indicated to open marginally higher on Thursday as the world appears to have better hopes for a Brexit framework out of Europe. Investors are having to grapple with ...
Read Full Story »

Are Shareholders Getting Enough in the Achillion Acquisition?

Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) shares skyrocketed on Wednesday morning after an announcement that the firm would be acquired by Alexion Pharmaceuticals Inc. (NASDAQ: ALXN). While shares are up sharply ...
Read Full Story »